On NAD+, mitochondria, and the architecture of cellular fatigue
For decades the conversation about cellular energy began and ended with ATP. We knew the mitochondria produced it, we knew exhaustion meant we'd run low, and we drank coffee to bridge the gap. The conversation has shifted.
NAD+ (nicotinamide adenine dinucleotide) is the coenzyme without which mitochondria cannot produce ATP at scale. Levels decline measurably with age. The decline accelerates under chronic stress, inflammation, and metabolic dysfunction. What we used to call "feeling your age" is, in many cases, downstream NAD+ insufficiency.
Our NMN 18,000 formulation provides 18,000 mg of nicotinamide mononucleotide per bottle — a direct NAD+ precursor with documented bioavailability when delivered in pharmaceutical-grade form. We pair it with quarterly third-party assays so members can see exactly what's in every batch.
The science is still being written. But the foundation is solid: support the precursor, support the cofactor, support the rest of the cellular machinery in turn.